T
The Parkinson's and Movement Disorder Institute | Neurology Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
APL-130277
ENT-01
Pimavanserin
Moxifloxacin
PF-06649751
Droxidopa
E2007
Piclozotan
JZP385
Staccato Apomorphine
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 18 total trials
To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.
Active, not recruiting
Multiple System Atrophy
Drug: Placebo
Drug: Lu AF82422
This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...
Enrolling
MSA - Multiple System Atrophy
Symptomatic Neurogenic Orthostatic Hypotension
Drug: Ampreloxetine
Drug: Placebo
Trial sponsors
E
I
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems